Terms: = Gastric cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
62 results:
1. Circulating tumor DNA predicts recurrence and assesses prognosis in operable gastric cancer: A systematic review and meta-analysis.
Mi J; Wang R; Han X; Ma R; Li H
Medicine (Baltimore); 2023 Dec; 102(48):e36228. PubMed ID: 38050202
[TBL] [Abstract] [Full Text] [Related]
2. Short Telomere Lesions with Dysplastic Metaplasia Histology May Represent Precancerous Lesions of
Fujiwara-Tani R; Takagi T; Mori S; Kishi S; Nishiguchi Y; Sasaki T; Ikeda M; Nagai K; Bhawal UK; Ohmori H; Fujii K; Kuniyasu H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834592
[TBL] [Abstract] [Full Text] [Related]
3. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
[TBL] [Abstract] [Full Text] [Related]
4. Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker.
Sahm V; Maurer C; Baumeister T; Anand A; Strangmann J; Schmid RM; Wang TC; Quante M
Oncotarget; 2022; 13():347-359. PubMed ID: 35178191
[TBL] [Abstract] [Full Text] [Related]
5. tert Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas.
Gupta S; Won H; Chadalavada K; Nanjangud GJ; Chen YB; Al-Ahmadie HA; Fine SW; Sirintrapun SJ; Strong VE; Raj N; Lagunes DR; Vanderbilt CM; Berger MF; Ladanyi M; Dogan S; Tickoo SK; Reuter VE; Gopalan A
Endocr Pathol; 2022 Jun; 33(2):304-314. PubMed ID: 34549366
[TBL] [Abstract] [Full Text] [Related]
6.
Shi X; Li Q; Zhang L; Hanyu M; Xie L; Hu K; Nagatsu K; Zhang C; Wu Z; Wang F; Zhang MR; Yang K; Zhu R
Bioconjug Chem; 2021 Aug; 32(8):1763-1772. PubMed ID: 34260853
[TBL] [Abstract] [Full Text] [Related]
7. Detection of tert Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error.
Lee H; Lee B; Kim DG; Cho YA; Kim JS; Suh YL
Cancer Res Treat; 2022 Jan; 54(1):75-83. PubMed ID: 33940787
[TBL] [Abstract] [Full Text] [Related]
8. [Application of fecal DNA methylation biomarkers detection in gastric cancer screening].
Guo P; Zhou XJ; Xu L; Chen H; Zhao L; Sun MH; Hu H
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):808-812. PubMed ID: 33765723
[No Abstract] [Full Text] [Related]
9. Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy.
Yoo SH; Kang SY; Yoon J; Kim TY; Cheon GJ; Oh DY
Sci Rep; 2021 Jan; 11(1):296. PubMed ID: 33436659
[TBL] [Abstract] [Full Text] [Related]
10. Genetic variations associated with telomere length affect the risk of gastric carcinoma.
Lili M; Yuxiang F; Zhongcheng H; Ying S; Ru C; Rong X; Jiang L
Medicine (Baltimore); 2020 Jun; 99(23):e20551. PubMed ID: 32502020
[TBL] [Abstract] [Full Text] [Related]
11. Targeted-gene sequencing of an undifferentiated gallbladder carcinoma: a case report.
Xiao Y; Xiang C; Yang D; Zhao B; Li Y; Yin H
Diagn Pathol; 2020 Jun; 15(1):66. PubMed ID: 32487254
[TBL] [Abstract] [Full Text] [Related]
12. Genomic and epigenomic EBF1 alterations modulate tert expression in gastric cancer.
Xing M; Ooi WF; Tan J; Qamra A; Lee PH; Li Z; Xu C; Padmanabhan N; Lim JQ; Guo YA; Yao X; Amit M; Ng LM; Sheng T; Wang J; Huang KK; Anene-Nzelu CG; Ho SWT; Ray M; Ma L; Fazzi G; Lim KJ; Wijaya GC; Zhang S; Nandi T; Yan T; Chang MM; Das K; Isa ZFA; Wu J; Poon PSY; Lam YN; Lin JS; Tay ST; Lee MH; Tan ALK; Ong X; White K; Rozen SG; Beer M; Foo RSY; Grabsch HI; Skanderup AJ; Li S; Teh BT; Tan P
J Clin Invest; 2020 Jun; 130(6):3005-3020. PubMed ID: 32364535
[TBL] [Abstract] [Full Text] [Related]
13. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations.
Zhang Y; Chen F; Fonseca NA; He Y; Fujita M; Nakagawa H; Zhang Z; Brazma A; ; ; Creighton CJ;
Nat Commun; 2020 Feb; 11(1):736. PubMed ID: 32024823
[TBL] [Abstract] [Full Text] [Related]
14. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells.
Panneerpandian P; Devanandan HJ; Marimuthu A; Karthikeyan C; Ganesan K
Antiviral Res; 2020 Feb; 174():104695. PubMed ID: 31846633
[TBL] [Abstract] [Full Text] [Related]
15. The htert-VNTR2-2
Kwon JA; Jeong MS; Yoon SL; Mun JY; Kim MH; Yang GE; Park SH; Chung JW; Choi YH; Cha HJ; Leem SH
Genes Genomics; 2019 Dec; 41(12):1517-1525. PubMed ID: 31691174
[TBL] [Abstract] [Full Text] [Related]
16. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
Dekempeneer Y; Bäck T; Aneheim E; Jensen H; Puttemans J; Xavier C; Keyaerts M; Palm S; Albertsson P; Lahoutte T; Caveliers V; Lindegren S; D'Huyvetter M
Mol Pharm; 2019 Aug; 16(8):3524-3533. PubMed ID: 31268724
[TBL] [Abstract] [Full Text] [Related]
17. A new era for understanding genetic evolution of multistep carcinogenesis.
Shimada S; Tanaka S
J Gastroenterol; 2019 Jul; 54(7):667-668. PubMed ID: 30923915
[TBL] [Abstract] [Full Text] [Related]
18. Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression.
Zhang B; Ling T; Zhaxi P; Cao Y; Qian L; Zhao D; Kang W; Zhang W; Wang L; Xu G; Zou X
Cancer Lett; 2019 Jun; 452():23-30. PubMed ID: 30910586
[TBL] [Abstract] [Full Text] [Related]
19. Genetic variations associated with telomere length confer risk of gastric cardia adenocarcinoma.
Zhang N; Zheng Y; Liu J; Lei T; Xu Y; Yang M
Gastric Cancer; 2019 Nov; 22(6):1089-1099. PubMed ID: 30900102
[TBL] [Abstract] [Full Text] [Related]
20. ASF1a inhibition induces p53-dependent growth arrest and senescence of cancer cells.
Wu Y; Li X; Yu J; Björkholm M; Xu D
Cell Death Dis; 2019 Jan; 10(2):76. PubMed ID: 30692519
[TBL] [Abstract] [Full Text] [Related]
[Next]
